Skip to Main Content

Paper Details

High and Sustained Ex Vivo Frequency but Altered Phenotype of SARS-CoV-2-Specific CD4<sup>+</sup> T-Cells in an Anti-CD20-Treated Patient with Prolonged COVID-19.
Viruses
5
2022
B-cell, B-cell depletion, B-cell-depleted, CD127, CD127 virus-specific effector cells, CD4, CD4 T, CD4 T-cell, CD4 T-cells, CD45RA, COVID-19, CRP, CXCR5, IL-6, LAG-3, MHC class II DRB1*11:01, PD-1, Patient, SARS, SARS-, SARS-CoV-2, SARS-CoV-2 membrane protein, SARS-CoV-2-Specific CD4 T-Cells, SARS-CoV-2-specific CD4 T-cells, T, T-cells, TIGIT, anti-CD20, cT, helper cell, patient, patients, specific CD4 T-cells, virus-specific CD4 T, virus-specific CD4 T-cell, virus-specific CD4 T-cells
Author NameAffiliation
William W KwokBenaroya Research Institute at Virginia Mason
Marylyn M AddoUniversity Medical Center Hamburg-Eppendorf
Marylyn M AddoGerman Center for Infection Research (DZIF)
  • 1 - 3

Datasets

Release 1.2